| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/2006 | US20060148697 Administering physiological agent that decreases or regulates blood or tissue levels, expression, production, function, or activity of luteinizing hormone (LH), LH receptors, follicle stimulating hormone (FSH), FSH receptor, androgenic steroid, androgenicsteroid receptors, an activin, activin receptor |
| 07/06/2006 | US20060148693 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148686 Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
| 07/06/2006 | US20060148684 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148678 Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products |
| 07/06/2006 | US20060148675 Methods of reducing angiogenesis |
| 07/06/2006 | US20060148674 Therapeutic composition |
| 07/06/2006 | US20060148020 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer |
| 07/06/2006 | US20060148014 Tubulin isotype screening in cancer therapy using hemiasterlin analogs |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060147989 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147907 Methods for detection of promoter polymorphism in a UGT gene promoter |
| 07/06/2006 | US20060147904 Use of resveratrol to regulate expression of apolipoprotein A1 |
| 07/06/2006 | US20060147609 Oilseed processing |
| 07/06/2006 | US20060147569 Anti-depression formulations |
| 07/06/2006 | US20060147568 Blood pressure-lowering agent, vascular flexibility -improving agent and foods having these functions imparted thereto |
| 07/06/2006 | US20060147566 Use of physiologically active fatty acids |
| 07/06/2006 | US20060147564 Composition for preventing or treating allergic disease using black rice extract and its therapeutic use |
| 07/06/2006 | US20060147558 Remedies |
| 07/06/2006 | US20060147552 Use of iron for treating attention deficit hyperactivity disorder in children |
| 07/06/2006 | US20060147551 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 07/06/2006 | US20060147550 Immune system enhancement and stimulation formulation |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147547 Bone enhancing composite |
| 07/06/2006 | US20060147544 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 07/06/2006 | US20060147540 Non-hygroscopic and powdery amorphous pimecrolimus |
| 07/06/2006 | US20060147539 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery |
| 07/06/2006 | US20060147538 Nanocomposite drug delivery composition |
| 07/06/2006 | US20060147537 utilizes an adsorbent material, such as a molecular sieve, that adsorbs moisture in the inner local environment of an impermeable package, to prevent formation of Maillard products which result from chemical reactions between drug and a reducing sugar in the medical device in the presence of moisture |
| 07/06/2006 | US20060147531 Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate |
| 07/06/2006 | US20060147530 Sustained release compositions containing alfuzosin |
| 07/06/2006 | US20060147528 Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation |
| 07/06/2006 | US20060147527 Controlled release preparations comprising tramadol and topiramate |
| 07/06/2006 | US20060147526 Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines |
| 07/06/2006 | US20060147525 Lipophilic drug compositions |
| 07/06/2006 | US20060147524 Melt-formulated, multi-particulate oral dosage form |
| 07/06/2006 | US20060147523 Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof |
| 07/06/2006 | US20060147522 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| 07/06/2006 | US20060147521 Sustained release ranolazine formulations |
| 07/06/2006 | US20060147520 Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
| 07/06/2006 | US20060147519 Process for the preparation of robust formulations of valacyclovir hydrochloride tablets |
| 07/06/2006 | US20060147518 Water soluble; vinorelbine ditartrate in polyoxyethylene glycol; for oral administration |
| 07/06/2006 | US20060147515 Bioactive dispersible formulation |
| 07/06/2006 | US20060147514 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/06/2006 | US20060147513 Methods of forming targeted liposomes loaded with a therapeutic agent |
| 07/06/2006 | US20060147511 Liposomal glucocorticoids |
| 07/06/2006 | US20060147510 Method for treating non-neuropathic pain |
| 07/06/2006 | US20060147508 Niacinamide and salicylic acid; bioavailability |
| 07/06/2006 | US20060147500 Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147495 Amino acid-based nutritional formulation |
| 07/06/2006 | US20060147492 Medical implants and anti-scarring agents |
| 07/06/2006 | US20060147488 increasing tear resistance of scar tissue during wound repair by applying to a wound a surgical mesh comprising an anabolic steroid and a corticosteroid disposed in or on a surgical mesh structure |
| 07/06/2006 | US20060147482 Oral liquid pharmaceutical composition of leukotriene antagonists |
| 07/06/2006 | US20060147481 Ketoprofen powder for oral use |
| 07/06/2006 | US20060147476 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 07/06/2006 | US20060147475 Ringworm vaccine |
| 07/06/2006 | US20060147462 For diagnostic, prophylactic and therapeutic uses, vaccines against bacterial infections |
| 07/06/2006 | US20060147457 Purified composition of bispecific molecules and methods of production |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060147440 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147416 Method of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myelodysplastic syndromes |
| 07/06/2006 | US20060147415 comprises sulfated saccharide conjugated to polymer; encapsulation; coronary disease, erectile dysfunction, myocardial infarction, ischemia, stroke, peripheral artery vascular disorder, neuronal injury, a spinal cord injury, trauma, neuropathy, Alzheimer's disease |
| 07/06/2006 | US20060147414 compound capable of carrying oxygen comprising dendron, dendrimer, hyperbranched polymer, or dendrigraft having a plurality of branches, each branch including a plurality of repeat units that contain a fluorocarbon moiety and peripheral hydrophilic moieties covalently bonded to terminal repeat units |
| 07/06/2006 | US20060147413 moldified polyallylamine with benzophenone, a 2-pyridyldithio groups; activated by irradiation and to form a covalent bond with a matrix; used for delivery of a biomaterial to a cell; polymer conjugated drug |
| 07/06/2006 | US20060147412 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
| 07/06/2006 | US20060147411 Novel compounds for the treatment of sickle cell disease |
| 07/06/2006 | US20060147409 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eye for minimal invasive surgery; crosslinked synthetic polymer having electrophilic functional groups and dilysine, trilysine or tetralysine; dyes provide green color |
| 07/06/2006 | US20060147405 Method for treating urushiol induced contact dermatitis |
| 07/06/2006 | US20060147401 Skin material for external use and antiprutiric agent for external use and wrinkle-instrument using the same |
| 07/06/2006 | US20060147398 Dendrite Elongation Inhibitor for Melanocyte and Skin Preparation for External Use Containing the Same |
| 07/06/2006 | US20060147397 Composition for preparation for external use on skin and method of using the same |
| 07/06/2006 | US20060147393 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas |
| 07/06/2006 | US20060147392 Agent for dissolving dental calculi and dental caries |
| 07/06/2006 | US20060147388 Pharmaceutical compositions for nasal delivery |
| 07/06/2006 | US20060147387 Process to minimize loss through adhesion to equipment surfaces |
| 07/06/2006 | US20060147386 System and method for intranasal administration of lorazepam |
| 07/06/2006 | US20060147385 Nasal spray steroid formulation and method |
| 07/06/2006 | US20060147384 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 07/06/2006 | US20060147383 Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase |
| 07/06/2006 | US20060147382 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| 07/06/2006 | US20060147380 Integrin targeted imaging agents |
| 07/06/2006 | US20060147376 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/06/2006 | US20060146723 Integrated circuit capable of transmitting probe packets across a stack of switches |
| 07/06/2006 | DE69635524T2 Antiparasitäre marcfortine und paraherquamide Antiparasitic marcfortines and paraherquamides |
| 07/06/2006 | DE202005020551U1 7-(4-Brombutoxy)-3,4-dihydrocarbostyril 7- (4-bromobutoxy) -3,4-dihydrocarbostyril |
| 07/06/2006 | DE112004001603T5 TGF-β-Genexpressionsinhibitor TGF-β gene expression inhibitor |
| 07/06/2006 | DE112004001572T5 Verfahren Method |
| 07/06/2006 | DE112004001520T5 Behandlung neurodegenerativer Erkrankungen Treatment of neurodegenerative diseases |
| 07/06/2006 | DE102005054092A1 Stereoisomer angereicherte 3-Aminocarbonyl-Bicyclohepten-Pyrimidindiamin-Verbindungen und deren Anwendungen Stereoisomer enriched 3-aminocarbonyl-bicycloheptene pyrimidinediamine compounds and their applications |
| 07/06/2006 | DE102004063227A1 Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tri-cyclic amino alcohols, processes for their preparation and their use as anti-inflammatories |
| 07/06/2006 | DE102004063132A1 Use of bupropion having tumor necrosis factor inhibitory activity for the preparation of a medicament for the treatment of hepatitis C |
| 07/06/2006 | DE102004062544A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel New substituted pyrrolidinones, their preparation and their Verewendung as medicaments |
| 07/06/2006 | DE102004062475A1 Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung Solid, orally administered pharmaceutical dosage forms with modified release |
| 07/06/2006 | DE102004062257A1 Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung Directly compressed indapamide sustained release tablets |